Literature DB >> 33532309

Value of preoperative urine white blood cell and nitrite in predicting postoperative infection following percutaneous nephrolithotomy: a meta-analysis.

Shuhao Ruan1, Zhiyong Chen1, Zewu Zhu1, Huimin Zeng1, Jinbo Chen1, Hequn Chen1.   

Abstract

BACKGROUND: To evaluate to what degree preoperative urine white blood cell (WBC) and urine nitrite (NIT) values are predictive of postoperative infections following percutaneous nephrolithotomy (PCNL).
METHODS: A systematic literature search was performed of the PubMed, Embase, Cochrane Library, Wanfang Data, National Knowledge Infrastructure (CNKI), and China Science and Technology Journal Database (CSTJ or VIP) online databases to identify relevant studies that examined the predictive value of urine WBC or NIT as risk factors for post-PCNL infection, and the search was finished on February 28, 2020. Two independent reviewers screened the relevant studies, extracted necessary data from the eligible case-control studies (CCS), and assessed the quality of included studies through the Newcastle-Ottawa scale (NOS). RevMan 5.3 software and the Stata 16.0 software were used to complete the statistical analysis of data. Results are expressed as odds ratio (OR) with 95% confidence intervals (CIs).
RESULTS: According to the statistical analysis of 12 eligible studies involving 6113 patients, positive urine WBC (WBC+: OR =3.86, 95% CI: 3.03-4.91, P<0.001) and positive NIT (NIT+: OR =7.81, 95% CI: 5.44-11.21, P<0.001) in preoperative tests were identified as independent risk factors for postoperative infections following PCNL.
CONCLUSIONS: In summary, as risk factors for postoperative infections, the presence of preoperative urine WBC+ and NIT+ should be evaluated as part of clinical procedure, in order to reduce infections of PCNL. 2021 Translational Andrology and Urology. All rights reserved.

Entities:  

Keywords:  Percutaneous nephrolithotomy (PCNL); postoperative infections; urine nitrite; urine white blood cell (urine WBC)

Year:  2021        PMID: 33532309      PMCID: PMC7844477          DOI: 10.21037/tau-20-930

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


Introduction

Urinary stones commonly present in urological ward patients (1). Since first being described in 1976 (2), percutaneous nephrolithotomy (PCNL) has been one of the main methods of removing upper urinary tract stones (3). As a minimally invasive surgery involving a small incision, more rapid recovery, and higher stone clearance rate, PCNL has been the first-line treatment for kidney stones >2 cm and stones that have a more complex presentation (1). With the development of radiology, ultrasonography, endoscopy, and lithotripsy equipment, the safety and efficacy of PCNL have improved significantly in recent decades. However, surgical complications, especially various infections, remain a cause for concern (3,4). Fever is one of the common signs of urinary tract infections (UTIs), and may signal the onset of severe UTIs. Systemic inflammatory response syndrome (SIRS) is a common post-PCNL infectious complication that may be confused with urosepsis by clinical medical staff. Urosepsis, identified as the most serious postoperative infectious complication in urological wards, is one type of sepsis related to UTIs (5). Without timely treatment, urosepsis may progress rapidly to uroseptic shock and even multiple organ dysfunction syndrome (MODS), which can be life-threatening (6). Consequently, early prediction and diagnosis of infections is critical in guiding perioperative antibiotic therapy and in reducing serious postoperative infections. Urine culture is one of several effective measures in the diagnosis of UTIs, but it requires significant time for bacterial culture and may also be compromised by sample contamination. More commonly, clinical urologists prefer to use routine urine tests as a diagnostic tool in their daily practice, because they are less costly and time-consuming. In routine urine tests of patients with urolithiasis, the commonly observed index value includes white blood cell (WBC), red blood cell, and nitrite (NIT) levels. Urinary NIT paired with urine WBC has reportedly been used in diagnosis of UTIs with high accuracy (7). This raises the question of whether or not post-PCNL infections can be predicted by NIT or WBC in preoperative urine tests. Although there have been several relevant individual studies exploring the risk factors of post-PCNL infections, no meta-analysis has been conducted to summarize the existing data. Therefore, we pooled and analyzed current relevant studies to evaluate to what degree preoperative urine WBC and NIT values are predictive of postoperative infections following PCNL. We present the following article in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting checklist (available at http://dx.doi.org/10.21037/tau-20-930) (8).

Methods

Our study has been registered in International Platform of Registered Systematic Review and Meta-analysis Protocols (registration number INPLASY202060048).

Data sources and search

Two authors independently searched relevant studies in the PubMed, Embase, Cochrane Library, Wanfang Data, National Knowledge Infrastructure (CNKI), and China Science and Technology Journal Database (CSTJ or VIP) online databases, and the search was finished on February 28, 2020. The search terms were: (“Percutaneous Nephrolithotomy” OR “Percutaneous Nephrolithotripsy” OR “PCNL” OR “MPCNL”) AND (“Leukocyte” OR “White Blood Cell” OR “WBC” OR “Nitrite”) AND (“Infection” OR “Fever” OR “Sepsis” OR “Urosepsis” OR “Systemic Inflammatory Response Syndrome” OR “SIRS” OR “Shock”). Given the likelihood of potentially relevant studies with high value being included in the reference lists of identified studies, all reference lists were also screened.

Inclusion and exclusion criteria

Inclusion criteria for the selected relevant studies were the following: (I) the full-text article published in English or Chinese; (II) a case-control study (CCS); (III) data with preoperative urine WBC or NIT. The exclusion criteria were the following: (I) case reports, conference reports, review articles, and meta-analyses; (II) emergency surgeries; (III) duplicate publications of similar studies from the same author or organization.

Screening of articles

According to the PRISMA flow diagram (8), the search results from the online databases were imported into the EndNote X9.2 software downloaded from the online library of Central South University. Two independent authors screened the title and abstract of each study and excluded those that were duplicates or irrelevant. The full-text articles of the remaining potential studies were downloaded and reviewed carefully. Finally, any disagreement between the two authors was solved by a third independent author or through discussion.

Data extraction and quality assessment

Relevant data were extracted from the eligible studies by two independent authors, and the consistency between the data was checked by a third independent author. The extracted data included the author names, published year, study types, sample size, race, gender, age, preoperative urine test, and postoperative infectious complications. Two independent authors assessed the quality of the eligible CCS using the Newcastle-Ottawa scale (NOS) (9).

Data synthesis and statistical analysis

In selected articles, the value of preoperative urine WBC or NIT in predicting postoperative infectious complications was compared in patients undergoing PCNL. The primary outcome data were postoperative sepsis, urosepsis or SIRS, while the secondary outcome data were postoperative fever or septic shock. In this meta-analysis, the Review Manager software (RevMan Version 5.3, Cochrane Collaboration, Oxford, UK) and the STATA software (Stata version 16.0, Stata Corp LP, College Station, TX, USA), were used to complete the statistical analysis of data. Data type was dichotomous data and the effect measure was odds ratio (OR) with a confidence interval (CI) of 95% (95% CI). Mantel-Haenzsel (M-H) was used as the statistical method. The statistical heterogeneity among included studies was tested by the Chi-square test, including the Cochran Q test and I2 test (10). When no significant statistical heterogeneity was detected (both I2 <50% and P>0.10), the fixed effects (FE) model was used. Otherwise, the random effects (RE) model was used. Because the I2 was unknown initially, the RE model was used provisionally. If significant statistical heterogeneity was present, sensitivity analyses were used to evaluate the reliability of the result, by omitting each study individually.

Results

Eligible studies, characteristics and quality assessment

According to the search method, 419 potentially relevant studies were identified from the six online databases (PubMed =36, Embase =71, Cochrane =12, CNKI =93 and Wanfang =98, VIP =109). Based on inclusion and exclusion criteria, 207 studies remained after duplicates were removed, a further 18 studies remained after abstract screening, and a final 12 studies remained after full-text review. The selection of studies is shown in , and the basic characteristics and bias risk assessment of the 12 eligible studies (11-22), are individually shown in .
Figure 1

PRISMA flow diagram of study selection. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.

Table 1

Basic characteristics of eligible studies

StudyLanguageTypeRaceGander (F/M)Age (years)Risk factor in urine testInfection type
WBCNIT
Ailaiti W 2019, (11)ChineseCCSAsian130/284NAWBC ≥1+NIT+SIRS
Cao G 2016, (12)ChineseCCSAsian499/1,09122–69WBC ≥3+NAShock
Chen D 2019, (13)EnglishCCSAsian332/47052.0±12.2WBC ≥2+NIT+Sepsis
Chen M 2018, (14)ChineseCCSAsian74/7631–65WBC ≥2+NAFever
Fan J 2017, (15)ChineseCCSAsian187/25149.4±11.1WBC ≥1+NIT+SIRS
He Y 2016, (16)ChineseCCSAsian34/2857.76±12.53WBC ≥2+NAFever
He Z 2018, (17)EnglishCCSAsian459/57152.05±11.94WBC ≥1+NASIRS
Luan G 2018, (18)ChineseCCSAsian194/9950.41±11.48WBC ≥3+NASepsis
Wang X 2018, (19)ChineseCCSAsian28/5252.04±3.95WBC ≥3+NASepsis
Wang Y 2012, (20)EnglishCCSAsian170/25013–70WBC ≥1+NAShock
Zhu Z 2020, (21)EnglishCCSAsian202/48355.5WBC ≥1+NIT+Sepsis
Zou S 2014, (22)ChineseCCSAsian20/2863.2±18.5NANIT+Shock

F/M, female/male; SD, standard deviation; NIT+, positive nitrite; WBC+, positive WBC, urine WBC >25/μL or >5/HP (high-power field), WBC 1+, 5–10/HP, WBC 2+: 10–15/HP, WBC 3+: 15–20/HP, WBC 4+: ≥20/HP; CCS, case-control study; NA, not applicable.

Table 2

Bias risk assessment of eligible studies

StudySelectionComparabilityExposureNOS score
ABCDEFGHI
Ailaiti W 20191101101117
Cao G 20161101101117
Chen D 20191101101117
Chen M 20181101101117
Fan J 20171101101117
He Y 20161101101117
He Z 20181101101117
Luan G 20181101101117
Wang X 20181101101117
Wang Y 20121101101117
Zhu Z 20201101101117
Zou S 20141101101117

A, adequate case definition; B, representativeness of the cases; C, selection of controls; D, definition of controls; E, study controls for the most important factor; F, study controls for any additional factor; G, ascertainment of exposure; H, same method of ascertainment for cases and controls; I, non-response rate; NOS: Newcastle-Ottawa scale, the NOS score ranges from 0 to 9, the higher score means the lower risk of bias and the score ≤5 means a high risk of bias.

PRISMA flow diagram of study selection. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses. F/M, female/male; SD, standard deviation; NIT+, positive nitrite; WBC+, positive WBC, urine WBC >25/μL or >5/HP (high-power field), WBC 1+, 5–10/HP, WBC 2+: 10–15/HP, WBC 3+: 15–20/HP, WBC 4+: ≥20/HP; CCS, case-control study; NA, not applicable. A, adequate case definition; B, representativeness of the cases; C, selection of controls; D, definition of controls; E, study controls for the most important factor; F, study controls for any additional factor; G, ascertainment of exposure; H, same method of ascertainment for cases and controls; I, non-response rate; NOS: Newcastle-Ottawa scale, the NOS score ranges from 0 to 9, the higher score means the lower risk of bias and the score ≤5 means a high risk of bias.

Postoperative infections and urine WBC

Eleven of the eligible studies reported that preoperative urine WBC positive was an independent risk factor for postoperative infections, while there were different grouping criteria of urine WBC results, including WBC ≥1+, WBC ≥2+, and WBC ≥3+. Five studies (SIRS: Ailaiti W 2019, Fan J 2017, and He Z 2018; Urosepsis: Zhu Z 2020; Septic shock: Wang Y 2012) reported that the ratios of postoperative infections in patients with WBC ≥1+ (3.6–20.8%) were individually higher than WBC 1+ (1.6–11.8%), with a significant difference between the two groups (OR =2.98, 95% CI: 2.25–3.93, P<0.001, ), with no statistical heterogeneity being detected across the five studies (I2 =16%, P=0.31).
Figure 2

Postoperative infections and urine WBC. WBC, white blood cell; M-H, Mantel-Haenzsel; CI, confidence interval.

Postoperative infections and urine WBC. WBC, white blood cell; M-H, Mantel-Haenzsel; CI, confidence interval. Three studies (fever: Chen M 2018 and He Y 2016; urosepsis: Chen D 2019) reported that the ratios of postoperative infections in patients with WBC ≥2+ (5.8–43.2%) were individually higher than WBC <2+ (0.4–12.0%), with a significant difference between the two groups (OR =6.36, 95% CI: 3.21–12.59, P<0.001, ) and no statistical heterogeneity being detected across the three studies (I2 =18%, P=0.29). Three studies (urosepsis: Luan G 2018 and Wang X 2018; shock: Cao G 2016) reported that the ratios of postoperative infections in patients with WBC ≥3+ (3.8–44.4%) were individually higher than those of WBC<3+ (0.3–2.8%), with a significant difference between the two groups (OR =15.69, 95% CI: 6.87–35.84, P<0.001, ) and no statistical heterogeneity being detected across the three studies (I2 =0%, P=0.68). In total, the positive groups were at significantly higher risk of postoperative infections than the negative groups individually (OR =3.86, 95% CI: 3.03–4.91, P<0.001, ). However, statistical heterogeneity (I2 =62%, P=0.004) and heavy statistical heterogeneity (I2 =87.9%, P=0.0003) were individually detected among the 11 studies and the 3 subgroups, both of which were mainly caused by the different grouping criteria of different subgroups.

Postoperative infections and urine NIT

Five eligible studies reported that preoperative urine NIT positive was an independent risk factor for postoperative infections (SIRS: Ailaiti W 2019 and Fan J 2017; urosepsis: Chen D 2019 and Zhu Z 2020; septic shock: Zou S 2014). The ratios of postoperative infections in the positive groups (8.7–43.8%) were individually higher than the ratios in the negative groups (0.9–9.9%), with a significant difference between the two groups (OR =7.81, 95% CI: 5.44–11.21, P<0.001, ), and no significant statistical heterogeneity being detected across the five studies (I2 =0%, P=0.43).
Figure 3

Postoperative infections and urine NIT. NIT, nitrite; M-H, Mantel-Haenzsel; CI, confidence interval.

Postoperative infections and urine NIT. NIT, nitrite; M-H, Mantel-Haenzsel; CI, confidence interval.

Postoperative infections and urine WBC & NIT

Additionally, Chen et al. reported that combined WBC+ and NIT+ in preoperative urine tests was considered an early and rapid predictor of post-PCNL urosepsis (OR =3.9, 95% CI: 1.2–12.1, P=0.021), and the incidence of postoperative infections (fever, SIRS and urosepsis) in the group of patients with combined WBC+ and NIT+ was significantly higher than that in the groups of patients with WBC− and NIT−, WBC+ and NIT−, or WBC− and NIT+ (P<0.01) (13). Zhu et al. also reported that positive NIT, WBC, and leukocyte esterase (LE) (NIT+, WBC+, and LE+) in preoperative urine tests was an independent risk factor for urinary sepsis (OR =17.51, 95% CI: 6.75–45.38, P<0.001) (21).

Publication bias and sensitivity analyses

Through the inverted funnel plot visual inspection, no significant publication bias was found in the present study (). Additionally, the sensitivity analyses were performed by individually omitting every eligible study, and the statistical robustness tests in the two comparisons were both successful ().
Figure 4

Funnel plot of comparison regarding (A) WBC and (B) NIT. WBC, white blood cell; NIT, nitrite; SE, standard error; OR, odds ratio.

Figure 5

Sensitivity analysis of comparison regarding (A) WBC and (B) NIT. WBC, white blood cell; NIT, nitrite; CI, confidence interval.

Funnel plot of comparison regarding (A) WBC and (B) NIT. WBC, white blood cell; NIT, nitrite; SE, standard error; OR, odds ratio. Sensitivity analysis of comparison regarding (A) WBC and (B) NIT. WBC, white blood cell; NIT, nitrite; CI, confidence interval.

Discussion

Although there has been considerable progress achieved in PCNL since 1976, postoperative infectious complications following PCNL continue to be problematic for urologists. Therefore, it is necessary to identify risk factors for post-PCNL infections in order to predict the likelihood of postoperative infections. Our meta-analysis conclusively indicated that positive WBC and NIT in preoperative urine tests were two independent risk factors for postoperative infectious complications in patients undergoing PCNL. Of the eligible studies, five compared WBC+ with WBC− (OR =2.98, P<0.001), three compared WBC ≥2+ with WBC <2+ (OR =6.36, P<0.001), and three compared WBC ≥3+ with WBC <3+ (OR =15.69, P<0.001). Patients with positive urine WBC had a significantly higher risk of postoperative infections. For instance, Wang et al. reported that the ratio of septic shock in patients with urine WBC ≥25/µL was four times higher than that of patients with WBC <25/µL (20); furthermore, Chen et al. reported that the ratio of urosepsis in patients with urine WBC ≥10/HP was 14.9 times higher than that in patients with WBC <10/HP (13). Consistently, WBC counting in urine sediment microscopy and NIT in urine tests could be used in the diagnosis of UTIs (7). Additionally, recurrent UTI was reported as an independent risk factor for both post-PCNL SIRS (OR =2.08, 95% CI: 1.03–4.20, P=0.04) and sepsis (OR =23.71, 95% CI: 3.75–150.04, P=0.01) (5). Five studies compared NIT+ with NIT− (OR =7.81, P<0.001). The ratios of postoperative SIRS in patients with NIT+, were 3.8–5.4 times higher than those of NIT0032 (11,15), and the ratios of postoperative urosepsis in patients with NIT+, were 9.4–11.5 times higher than those of NIT− (13,21). Additionally, in another relevant study of the same first author, Fan et al. reported that positive urine NIT was also an independent risk factor in uroseptic shock in patients with post-PCNL SIRS (OR =10.570, P=0.025) (23). Bacteria in the urine tract can convert nitrate to NIT, and then the NIT dipstick can test this rapidly and measure bacteriuria indirectly, which can be used in the diagnosis of UTIs with high specificity (95%) but low sensitivity (51%) (24). Furthermore, the presence of urine LE, tested by the LE dipstick, could significantly increase the diagnostic accuracy of UTIs. The sensitivity and specificity of urine dipstick (nitrate and LE in combination) was 22.9% and 99.1% individually (24). It was also reported that urine NIT paired with WBC could significantly increase the diagnostic accuracy of UTIs, and that the disjunctive pairing of NIT and WBC in patients whose bladder incubation time ≥4 hours had higher efficacy (84%) than the NIT (81%) and the WBC (72%), with high specificity (95%) but low sensitivity (41%) (7). The advantage of a urine test of WBC and NIT is that it takes only a few hours, whereas urine culture and drug sensitive tests need several days, which may delay diagnosis and treatment. Consequently, urine tests of WBC and NIT should be regarded as the method of choice for predicting postoperative infections on urological wards. There were several limitations in the present study. First, only 12 studies conducted in hospitals of different levels in China met our inclusion criteria, which might have created a risk of bias. Second, there were differences in postoperative infectious complications among the included studies, which included fever, SIRS, sepsis, and shock. Third, there were other confounding risk factors that cannot be ignored including female sex, older age, higher body mass index (BMI), persistent urinary obstruction, severe hydronephrosis, higher stone burden, infectious stones, longer operation time, and antibiotic therapy (5,13,20,21,25). Therefore, more case control studies with larger sample sizes and detailed data may be needed to optimize the reliability of the present study.

Conclusions

Both NIT+ and WBC+ in preoperative urine tests have been found to be independent risk factors for postoperative infectious complications of patients undergoing PCNL. Accordingly, to reduce the occurrence of severe postoperative infections, it is suggested that urologists pay close attention to PCNL patients with preoperative urine WBC+ or NIT+ values, and especially combined WBC+ and NIT+ values. The article’s supplementary files as
  17 in total

1.  Percutaneous pyelolithotomy. A new extraction technique.

Authors:  I Fernström; B Johansson
Journal:  Scand J Urol Nephrol       Date:  1976

2.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.

Authors:  Andreas Stang
Journal:  Eur J Epidemiol       Date:  2010-07-22       Impact factor: 8.082

3.  Prevention and treatment of septic shock following mini-percutaneous nephrolithotomy: a single-center retrospective study of 834 cases.

Authors:  Chunlai Liu; Xiling Zhang; Yili Liu; Ping Wang
Journal:  World J Urol       Date:  2012-12-18       Impact factor: 4.226

4.  The evaluation of early predictive factors for urosepsis in patients with negative preoperative urine culture following mini-percutaneous nephrolithotomy.

Authors:  Zewu Zhu; Yu Cui; Huimin Zeng; Yongchao Li; Feng Zeng; Yang Li; Zhiyong Chen; Chen Hequn
Journal:  World J Urol       Date:  2019-12-11       Impact factor: 4.226

5.  Predictors for uroseptic shock in patients who undergo minimally invasive percutaneous nephrolithotomy.

Authors:  Junhong Fan; Shawpong Wan; Luhao Liu; Zhijian Zhao; Zanlin Mai; Dong Chen; Wei Zhu; Zhou Yang; Lili Ou; Wenqi Wu
Journal:  Urolithiasis       Date:  2017-02-22       Impact factor: 3.436

6.  The Clinical Application of New Generation Super-Mini Percutaneous Nephrolithotomy in the Treatment of ≥20 mm Renal Stones.

Authors:  Chao Cai; Yang Liu; Wen Zhong; Wei Zhu; Zhijian Zhao; Wenqi Wu; Yongda Liu; Guohua Zeng
Journal:  J Endourol       Date:  2019-03-07       Impact factor: 2.942

7.  Early and rapid prediction of postoperative infections following percutaneous nephrolithotomy in patients with complex kidney stones.

Authors:  Dong Chen; Chonghe Jiang; Xiongfa Liang; Fangling Zhong; Jian Huang; Yongping Lin; Zhijian Zhao; Xiaolu Duan; Guohua Zeng; Wenqi Wu
Journal:  BJU Int       Date:  2018-08-09       Impact factor: 5.588

Review 8.  EAU Guidelines on Interventional Treatment for Urolithiasis.

Authors:  Christian Türk; Aleš Petřík; Kemal Sarica; Christian Seitz; Andreas Skolarikos; Michael Straub; Thomas Knoll
Journal:  Eur Urol       Date:  2015-09-04       Impact factor: 20.096

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21

10.  High Diagnostic Accuracy of Nitrite Test Paired with Urine Sediment can Reduce Unnecessary Antibiotic Therapy.

Authors:  Sven A Ferry; Stig E Holm; B Magnus Ferry; Tor J Monsen
Journal:  Open Microbiol J       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.